Image 1
Rasagiline Tablet
Product Images NDC 0093-3060
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rasagiline (NDC 0093-3060). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This text appears to be a label or packaging information for a medication called Rasagiline that comes in tablet form. It includes details such as the serialization coding area, the product name, and some identification numbers.*
Image 3
This is the packaging information for Rasagiline tablets produced by Teva Pharmaceuticals. There is a code for serialization and identification purposes. The document also includes a revision number and date.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
